Blood Systems Research Institute
nav Investigator
Home About BSRI Investigators News Employment Financial Donations Contact
spacer About BSRI
spacer
 
spacer spacer
spacer
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
spacer
line
Charles Chiu

Charles Chiu, MD, PhD
Assistant Professor, Department of Laboratory Medicine, University of California, San Francisco (UCSF)
Director, UCSF-Abbott Viral Diagnostics and Discovery Center
Associate Director, UCSF Clinical Microbiology Laboratory, San Francisco, California.

The research in Charles’s laboratory is focused on the development of microarray and next-generation sequencing (NGS) technologies for pathogen discovery and infectious disease diagnosis.  Charles received his MD, PhD degree in Biophysics from the University of California, Los Angeles in 2001 and subsequently completed an internal medicine residency and clinical infectious diseases fellowship at University of California, San Francisco (UCSF).  As a postdoctoral fellow in the laboratory of Joseph DeRisi at UCSF, he was instrumental in clinical and translational research applications of the ViroChip, a microarray for comprehensive detection and surveillance of viruses in clinical samples.  Since founding the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) and starting his own laboratory at UCSF in the Department of Laboratory Medicine in 2008, Charles reported the discovery of titi monkey adenovirus, a novel pathogen that caused a fulminant pneumonia outbreak in a New World monkey colony with cross-species transmission to a human researcher, and the Bas-Congo rhabdovirus, a novel virus associated with an acute hemorrhagic fever outbreak in central Africa.  Currently, his laboratory is involved in a wide range of projects including (1) implementation of unbiased NGS assays for real-time clinical diagnosis in the microbiology laboratory, (2) identification of known and novel viruses associated with acute hemorrhagic fever, tickborne illnesses, encephalitis, and hepatitis, (3) development and validation of a bloodborne pathogen microarray for blood bank screening, and (4) development of cloud-compatible bioinformatics pipelines for pathogen detection in NGS data from clinical samples, and (5) transcriptome profiling of acute and chronic Lyme disease.  Charles is the principal investigator on multiple grants from the NIH and other institutions, and has more than 35 patents and peer-reviewed publications in major scientific journals.  He is currently collaborating with Drs. Eric Delwart, Satish Pillai, and Graham Simmons at the BSRI on projects involving pathogen discovery, metagenomics, viral quasispecies analysis, and characterization of the proteins of Bas-Congo rhabdovirus.

http://profiles.ucsf.edu/charles.chiu
http://vddc.ucsf.edu

http://labmed.ucsf.edu/about/faculty/labmed-cchiu.html

spacer
 

Steve Kleinman, MD
Kleinman Biomedical Research, Victoria and
Clinical Professor, Pathology and Laboratory Medicine and Centre for Blood Research, University of British Columbia, Vancouver, BC CANADA

Research Interests: Transfusion Medicine; Blood Safety

http://www.pathology.ubc.ca/

spacer
 

Nico Lelie, PhD
Lelie Research, Paris FRANCE

spacer
 

Willi McFarland, MD, PhD, MPH, & TM
Director HIV Epidemiology Section, San Francisco Department of Public Health; Associate Professor of Epidemiology and Biostatistics at the University of California, San Francisco; Faculty, UCSF Global Health Sciences, Prevention and Public Health Group

http://globalhealthsciences.ucsf.edu/PPHG/bios/mcfarland_willi.html

spacer
Kim Nguyen

Kim Nguyen, PhD
Senior Scientist for Cell Processing, Terumo BCT, Lakewood, CO

Kim received her AB in Chemistry from Princeton University in 1999, her PhD in Chemistry from Columbia University in 2005, and subsequently completed a postdoctoral fellowship with Josh Hare and Ian McNiece at the University of Miami focused on preclinical process translation and clinical cGMP scale-up of MSC, dendritic cell, and HSC cultures.  She also participated in the IND submissions  and GMP manufacturing of patient –infused products for  four clinical trials based upon the direct injection of MSC into the heart for myocardial infarction and dilated cardiomyopathy indications (PROMETHEUS, TAC-HFT,  POSEIDON, and POSEIDON-DCM trials). Kim joined Terumo BCT from the University of Miami in July 2010.

spacer
spacer
Ester Sabino

Ester C. Sabino, MD, PhD
Head, Department of Molecular Biology, Fundação Pró-Sangue/Hemocentro de Sao Paulo, and Associate Professor at the Department of Infectious Disease, University of Sao Paulo Medical School, BRAZIL

Research Interests:
Blood Borne Infectious Disease
Blood Safety
Chagas Disease
HIV Diversity

spacer
Phil Spinella

Phil Spinella, MD, FCCM
Associate Professor of Pediatrics and Director, Critical Care Translational Research Program, Washington University in St. Louis School of Medicine

Research Interests: Blood product storage lesion effects on microvasculature and clinical outcomes; Coagulation monitoring

http://peds.wustl.edu/

spacer
 

Phillip Williamson, PhD
Vice President, Scientific Affairs, Creative Testing Solutions (CTS), Tempe, Arizona

Research Interests: Development of rapid nucleic acid and immunologic diagnostic systems for vector-borne pathogens; Development of methods and tools for the rapid assessment of disease outbreaks; Metagenomic analysis of hematophagus arthropod microbiomes; Horizontal gene transfer in spotted fevers

   
 
spacer spacer
spacer